HomeNewsOpinionLife after the lockdown for NHAI is a collection of potholes

Life after the lockdown for NHAI is a collection of potholes

The new challenges come in the backdrop of a grim fiscal 2020 when toll revenue growth was negligible

June 02, 2020 / 10:49 IST
Story continues below Advertisement
Since the lockdown rules have lifted significantly, I’m sure a lot of you are itching to go out on a road trip. If you’re in the market looking for something that will help ferry the entire family, here’s a list we think could make that choice easier.
Since the lockdown rules have lifted significantly, I’m sure a lot of you are itching to go out on a road trip. If you’re in the market looking for something that will help ferry the entire family, here’s a list we think could make that choice easier.

The pandemic-led lockdown has deepened the potholes on the road ahead for the National Highways Authority of India (NHAI). The steep drop in toll collections and a slowdown in the pace of asset monetisation, which add to tight liquidity conditions, point to funding challenges for the NHAI. This could put the government body’s road works at risk, at least in the near term.

After all, these challenges come in the backdrop of a grim fiscal 2020 when toll revenue growth was negligible. The economic slowdown, revised axle-load norms and finally, the lockdown in the last week of March hit traffic movement. Even after lockdown restrictions have been eased, initial indicators show a sharp rebound in toll collections is unlikely.

Story continues below Advertisement

Rating agency ICRA Ltd estimates a 10-13 percent decline in toll collections across projects in fiscal year 2021.

On top of this, the NHAI’s efforts to raise funds through the toll-operate-transfer (TOT) model have also slipped into the slow lane. Of the four bundles to be awarded, only the first was a resounding success, which fetched the government about Rs 9,000 crore. Ironically, the second bundle was cancelled after it got a tepid response from investors. The third (which is awarded) and fourth that were expected to garner about Rs 10,000 crore by the end of fiscal 2020, are yet to be completed.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show